Search PubMed⌕ Search

Biomedical subjects

C Nakamura

Publications and source records attributed to C Nakamura.

At least 181 records · Page 10Linked to original sources

The developmental pattern of thyrotropin-releasing hormone-degrading activity in the plasma of rats.

The developmental pattern of TRH-degrading activity in rat plasma was determined by measuring the ability of plasma from rats of various ages to degrade TRH into degradation products. From a rate of 0.519 pmol TRH degraded/microliter-1.h-1 on day 8, plasma TRH-degrading activity increased to 18.1 pmol TRH by day 90 in female rats. The increase in rate of formation of proline, a major plasma degradation product, was in very good agreement with the increase in rate of TRH degradation. The major increase in TRH-degrading activity occurred between the third and seventh week of life. A similar pattern of development was observed in male rats; the only significant difference was that plasma from day 90 male rats was approximately 30% more active than that from female rats (P less than 0.002). Daily T3 administration to rats from days 8--26 resulted in a 2-fold increase in plasma TRH-degrading activity (P less than 0.05). The contribution of plasma degradation to the physiological control of TRH activity is not clear, but the magnitude of the increase in plasma TRH-degrading activity (approximately 30-fold) during the maturation of the rat is suggestive of a mechanism of biological significance.

Aging↗

Clinical evaluation of a new anticoagulant therapy in prosthetic valve replacement.

Thromboembolic complication was correlated with the methods of anticoagulant therapy used in the patients with Starr-Edwards non cloth-covered or cloth-covered ball valve. A new anticoagulant therapy combining Bucolome with Warfarin has been used for the patients who were unable to be maintained in a suitable range of thrombotest Owren with Warfarin alone. The results obtained in this new therapy showed that the incidence of thromboembolism was reduced to 0.02 per patient year or less in the patients with Starr-Edwards ball valve as well as Björk-Shiley tilting disc valve.

Aortic Valve↗

Surgical treatment of floppy mitral valve syndrome in children.

Five children whose ages ranged from 9 to 14 years underwent operation for floppy mitral valve syndrome. The clinical course of this syndrome in young patients was characterized by exceptionally rapid deterioration in congestive heart failure after the onset of symptoms. The children responded poorly to medical treatment. Early surgical treatment should be recommended soon after the onset of congestive heart failure. Three out of 5 patients required an associated tricuspid valve replacement for a floppy tricuspid valve, whose structure showed marked myxomatous transformation. Because of the high incidence of myxomatous transformation of the tricuspid valve in children, significant tricuspid insufficiency in this syndrome should be managed by valve replacement.

Adolescent↗